CBG (Cannabigerol) was first discovered in Israel by Raphael Mechoulam in 1964. He and his colleagues apparently did not understand how significant this was at the time. Nevertheless, it was this historic achievement that helped us establish the fundamental understanding of the cannabis plant that we have today.
Many people call CBG “the mother of all cannabinoids” because it is the source compound from which all other cannabinoids are synthesized. The unique properties of this compound continue to place it at the forefront of cannabinoid research. In the US, the farm bill legalized the production of hemp and the market for cannabinoids like CBG looks like it will continue to grow exponentially. The enthusiasm for cultivating and producing cannabinoid products shows no sign of slowing. But what is CBG and why is it so important?
Cannabigerol starts out in the form of cannabigerolic acid (CBGA) as the plant flowers and matures. This creates the properties needed for other cannabinoids. Furthermore, CBGA is synthesized into the likes of CBDA, and so forth. When these compounds become heated enough, they eventually lose the acid and become plain old CBD.
CBG communicates with the human body’s own endocannabinoid framework.
Scientists are still attempting to see precisely how cannabinoids act to influence the body’s common endocannabinoid framework. It appears that Cannabigerol, for the most part, ties with the body’s CB1 and CB2 receptors. The science here can get truly convoluted. However, the fundamental takeaway is the way CBG communicates with the body’s endocannabinoid system.
CBG is non-inebriating—which means it doesn’t create the “high” related with THC. Therefore, it may yield restorative and preventative advantages with no major psychological side effects. We are not at liberty to say whether or not CBG helps with the following:
- Psoriasis
- Cancer
- Bone Strength
- Bowel Disease
- Alzheimer’s
- Depression
- Anxiety
- Glaucoma
- Bladder Dysfunction
- Brain Health
- Pain